跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,407 条关于
“Adcock Ingram Holdings”
全部
3,407
临床试验
2,342
药物
89
机构
164
资讯
812
上个月
Natco Pharma Q1FY27 Net Profit Slumps 57% as Lenalidomide Revenue Declines
上个月
Natco Pharma Q1 Profit Slumps 57% on Lenalidomide Sales Erosion; Plans ₹2,000-Crore QIP for Acquisitions
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
去年
Callio Therapeutics Secures $187M Series A to Develop Novel Multi-Payload Cancer ADCs
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
ALX Oncology's Evorpacept Shows Promise in Multiple Cancer Trials
去年
CERO Therapeutics' CER-1236 Receives FDA Clearance for Clinical Trials
去年
Organovo Appoints Norman Staskey as CFO, Advancing IBD and MASH Programs
第 1 页,共 82 页
上一页
下一页